You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 2.9% | 3.2% |
| Div Cover | 1.5 | 2.2 |
| Op Mrgn | 36.3% | 47.2% |
| ROCE | 66.8% |
| Latest | Forecast | |
|---|---|---|
| P/E | 22.1 | 0.0 |
| PEG | 1.2 | 0.3 |
| Price / Revenue | 5.5 | 5.0 |
| Price / Book value | 39.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 1.3% | 3.5% |
| PBT | 9.6% | n/a |
| EPS | 17.8% | -0.2% |
| DPS | 10.1% | 2.2% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 23,747.00 | 9,545.00 | $12.70 | 15.3 | 0.0 | 369% | $5.28 | 2.7% |
| 2019-12-31 | 23,362.00 | 9,138.00 | $12.96 | 18.6 | 9.1 | 2% | $5.80 | 2.4% |
| 2020-12-31 | 25,424.00 | 8,133.00 | $12.40 | 18.5 | -4.3 | -4% | $6.56 | 2.9% |
| 2021-12-31 | 25,979.00 | 6,701.00 | $10.34 | 21.8 | -1.3 | -17% | $7.22 | 3.2% |
| 2022-12-31 | 26,323.00 | 7,346.00 | $12.18 | 21.6 | 1.2 | 18% | $7.95 | 3.0% |
| Horizon Therapeutics tanks as FTC expected to challenge Amgen deal Sharecast News | 16 May |
|---|---|
| Amgen to buy Horizon Therapeutics in $28.3bn deal Sharecast News | 12 Dec |
| Form 8.3 - Horizon Therapeutics plc | 07-Oct-23 00:09 |
|---|---|
| Form 8.3 - Horizon Therapeutics plc | 05-Oct-23 23:59 |
| Form 8.3 - Horizon Therapeutics plc | 05-Oct-23 23:59 |
| Form 8.3 - Horizon Therapeutics plc | 04-Oct-23 23:59 |
| Form 8.3 - Horizon Therapeutics plc | 04-Oct-23 23:59 |